These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
356 related articles for article (PubMed ID: 26662314)
1. Circulating long noncoding RNA GAS5 as a potential biomarker in breast cancer for assessing the surgical effects. Han L; Ma P; Liu SM; Zhou X Tumour Biol; 2016 May; 37(5):6847-54. PubMed ID: 26662314 [TBL] [Abstract][Full Text] [Related]
2. Circulating lncRNA H19 in plasma as a novel biomarker for breast cancer. Zhang K; Luo Z; Zhang Y; Zhang L; Wu L; Liu L; Yang J; Song X; Liu J Cancer Biomark; 2016 Jun; 17(2):187-94. PubMed ID: 27540977 [TBL] [Abstract][Full Text] [Related]
3. Identification of circulating long non-coding RNA GAS5 as a potential biomarker for non-small cell lung cancer diagnosisnon-small cell lung cancer, long non-coding RNA, plasma, GAS5, biomarker. Tan Q; Zuo J; Qiu S; Yu Y; Zhou H; Li N; Wang H; Liang C; Yu M; Tu J Int J Oncol; 2017 May; 50(5):1729-1738. PubMed ID: 28339045 [TBL] [Abstract][Full Text] [Related]
4. Expression levels of breast cancer-related GAS5 and LSINCT5 lncRNAs in cancer-free breast tissue: Molecular associations with age at menarche and obesity. Mansoori Y; Tabei MB; Askari A; Izadi P; Daraei A; Bastami M; Naghizadeh MM; Nariman-Saleh-Fam Z; Mansoori B; Tavakkoly-Bazzaz J Breast J; 2018 Nov; 24(6):876-882. PubMed ID: 29785740 [TBL] [Abstract][Full Text] [Related]
5. Large intergenic non-coding RNA-ROR as a potential biomarker for the diagnosis and dynamic monitoring of breast cancer. Zhao T; Wu L; Li X; Dai H; Zhang Z Cancer Biomark; 2017 Aug; 20(2):165-173. PubMed ID: 28869448 [TBL] [Abstract][Full Text] [Related]
6. Circulating long noncoding RNA GAS5 is a novel biomarker for the diagnosis of nonsmall cell lung cancer. Liang W; Lv T; Shi X; Liu H; Zhu Q; Zeng J; Yang W; Yin J; Song Y Medicine (Baltimore); 2016 Sep; 95(37):e4608. PubMed ID: 27631209 [TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA GAS5 can predict metastasis and poor prognosis: a meta-analysis. Song W; Wang K; Zhang RJ; Dai QX; Zou SB Minerva Med; 2016 Feb; 107(1):70-6. PubMed ID: 26763654 [TBL] [Abstract][Full Text] [Related]
8. Decreased expression of lncRNA GAS5 predicts a poor prognosis in cervical cancer. Cao S; Liu W; Li F; Zhao W; Qin C Int J Clin Exp Pathol; 2014; 7(10):6776-83. PubMed ID: 25400758 [TBL] [Abstract][Full Text] [Related]
9. Circulating lncRNA H19 may be a useful marker of response to neoadjuvant chemotherapy in breast cancer. Özgür E; Ferhatoğlu F; Şen F; Saip P; Gezer U Cancer Biomark; 2020; 27(1):11-17. PubMed ID: 31640083 [TBL] [Abstract][Full Text] [Related]
10. Low expression of long non-coding RNA GAS5 is associated with poor prognosis of patients with thyroid cancer. Guo LJ; Zhang S; Gao B; Jiang Y; Zhang XH; Tian WG; Hao S; Zhao JJ; Zhang G; Hu CY; Yan J; Luo DL Exp Mol Pathol; 2017 Jun; 102(3):500-504. PubMed ID: 28506768 [TBL] [Abstract][Full Text] [Related]
11. Interplay of lncRNA H19/miR-675 and lncRNA NEAT1/miR-204 in breast cancer. Müller V; Oliveira-Ferrer L; Steinbach B; Pantel K; Schwarzenbach H Mol Oncol; 2019 May; 13(5):1137-1149. PubMed ID: 30803129 [TBL] [Abstract][Full Text] [Related]
12. Circulating long noncoding RNAs H19 and GAS5 are associated with type 2 diabetes but not with diabetic retinopathy: A preliminary study. Fawzy MS; Abdelghany AA; Toraih EA; Mohamed AM Bosn J Basic Med Sci; 2020 Aug; 20(3):365-371. PubMed ID: 31999937 [TBL] [Abstract][Full Text] [Related]
13. Circulating long non-coding HOX transcript antisense intergenic ribonucleic acid in plasma as a potential biomarker for diagnosis of breast cancer. Zhang Y; Zhang K; Luo Z; Liu L; Wu L; Liu J Thorac Cancer; 2016 Nov; 7(6):627-632. PubMed ID: 27755794 [TBL] [Abstract][Full Text] [Related]
14. A Genetic Variant of rs145204276 in the Promoter Region of Long Noncoding RNA GAS5 Is Associated With a Reduced Risk of Breast Cancer. Tang Y; Wang Y; Wang X; Liu Y; Zheng K Clin Breast Cancer; 2019 Jun; 19(3):e415-e421. PubMed ID: 30846409 [TBL] [Abstract][Full Text] [Related]
15. The use of Human Inflammatory Response and Autoimmunity RT2 lncRNA PCR Array for plasma examination in breast cancer patients prior to therapy. Sterbova M; Pazourkova E; Santorova-Pospisilova S; Zednikova I; Tesarova P; Korabecna M Neoplasma; 2019 Jul; 66(4):641-646. PubMed ID: 30943749 [TBL] [Abstract][Full Text] [Related]
16. Clinical Significance of Long Non-coding RNA MALAT1 Expression in Tissue and Serum of Breast Cancer. Miao Y; Fan R; Chen L; Qian H Ann Clin Lab Sci; 2016 Jul; 46(4):418-24. PubMed ID: 27466303 [TBL] [Abstract][Full Text] [Related]
17. Do circulating long non-coding RNAs (lncRNAs) (LincRNA-p21, GAS 5, HOTAIR) predict the treatment response in patients with head and neck cancer treated with chemoradiotherapy? Fayda M; Isin M; Tambas M; Guveli M; Meral R; Altun M; Sahin D; Ozkan G; Sanli Y; Isin H; Ozgur E; Gezer U Tumour Biol; 2016 Mar; 37(3):3969-78. PubMed ID: 26482616 [TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNAs: novel prognostic biomarkers for liver metastases in patients with early stage colorectal cancer. Kong H; Wu Y; Zhu M; Zhai C; Qian J; Gao X; Wang S; Hou Y; Lu S; Zhu H Oncotarget; 2016 Aug; 7(31):50428-50436. PubMed ID: 27391432 [TBL] [Abstract][Full Text] [Related]
19. Detection and analysis of circulating large intergenic non-coding RNA regulator of reprogramming in plasma for breast cancer. Zhang K; Luo Z; Zhang Y; Wang Y; Cui M; Liu L; Zhang L; Liu J Thorac Cancer; 2018 Jan; 9(1):66-74. PubMed ID: 29090518 [TBL] [Abstract][Full Text] [Related]
20. Unleash multifunctional role of long noncoding RNAs biomarker panel in breast cancer: a predictor classification model. Toraih EA; El-Wazir A; Ageeli EA; Hussein MH; Eltoukhy MM; Killackey MT; Kandil E; Fawzy MS Epigenomics; 2020 Jul; 12(14):1215-1237. PubMed ID: 32812439 [No Abstract] [Full Text] [Related] [Next] [New Search]